FDA Should Validate Effectiveness Of Risk Management Tools, PhRMA Says
Executive Summary
FDA risk management programs should be evaluated by the agency to determine the value of their implementation, the Pharmaceutical Research & Manufacturers of America maintained during a public workshop on risk management April 10
You may also be interested in...
“Risk Management” May Be Too Risky For Pharmacy, NACDS Tells FDA
The participation of retail pharmacy in FDA-approved risk management programs may depend on "risk management" of a different kind: whether retailers feel sufficiently shielded from any added liability under novel regulatory schemes
“Risk Management” May Be Too Risky For Pharmacy, NACDS Tells FDA
The participation of retail pharmacy in FDA-approved risk management programs may depend on "risk management" of a different kind: whether retailers feel sufficiently shielded from any added liability under novel regulatory schemes
FDA Risk Management Plan: Four Levels, From Labeling To Restricted Access
FDA is proposing four levels of risk management programs for prescription drugs and biologics in a "Risk Management Programs" draft 1concept paper released March 6